OSR HEALTH, INC. Federal Income Tax Expense (Benefit), Continuing Operations
OSR HEALTH, INC. (OSRH) reported Federal Income Tax Expense (Benefit), Continuing Operations of $90.47 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Expense Statement › Income Tax
us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations · last filed 2024-05-15
- OSR HEALTH, INC. federal income tax expense (benefit), continuing operations for the quarter ending 2024-03-31 was $90.47K, a 208.56% increase year-over-year.
- OSR HEALTH, INC. federal income tax expense (benefit), continuing operations for the quarter ending 2023-03-31 was $29.32K.
- OSR HEALTH, INC. federal income tax expense (benefit), continuing operations for fiscal 2023 was $540.81K.
| Period end | Federal Income Tax Expense (Benefit), Continuing Operations 3 month | Federal Income Tax Expense (Benefit), Continuing Operations 12 month |
|---|---|---|
| 2024-03-31 | $90.47K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $540.81K 10-K · filed 2024-04-17 | |
| 2023-03-31 | $29.32K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |